HPF affects several acute myeloid leukemia (AML) cell lines, as well as primary cells from AML patients, through different mechanisms including upregulation of Noxa expression, mitochondrial membrane depolarization, activation of caspases and inhibition of protein kinase B (AKT) activity [30]. Here, AKT1 is linked to acute myeloid leukemia.